Alembic Pharmaceuticals informs about press release

27 Jan 2026 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%. Enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

773.25 -3.15 (-0.41%)
18-Feb-2026 13:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.80
Dr. Reddys Lab 1283.00
Cipla 1340.00
Zydus Lifesciences 906.40
Lupin 2245.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×